Outpatient penicillin allergy de-labeling in primary care—whom to target

2026/01/01 by Angie Ton, Dan Ilges · 1 voice
Immunology and Microbiology · Medicine · #Antibiotic Use and Resistance #Contact Dermatitis and Allergies #Drug-Induced Adverse Reactions

paper · pdf · doi:10.1017/ash.2026.10331

openalex publication_date 2026/01/01 · openalex created_date 2026/03/28 · openalex updated_date 2026/05/21

Abstract

Education and allergy referral via nurse-driven online messaging to patients (n = 1,284) with penicillin allergy labels (PALs) reduced PALs by 8.6%. The percentage decrease of "unknown" (14.8%) and "rash" (7.9%) PALs were higher vs "hives" (6.1%) and "itching" (1.4%) reaction types.

Discussions

• Outpatient penicillin allergy de-labeling in primary care—whom to target: [bsky, 1 points, 0 comments]

Related

• Penicillin allergy de-labelling implementation intervention in a UK hospital: a process evaluation, the patient experience
• Patients’ acceptance of a penicillin allergy de-labelling programme in primary care: a qualitative study
• Direct Oral Challenge for Penicillin Allergy: The International Network of Antibiotic Allergy Nations (iNAAN) Study
• Assessing a penicillin allergy de-labelling implementation intervention in a UK hospital: a process evaluation reporting healthcare workers’ experiences
• Direct oral amoxicillin challenge in a tertiary care center: validating PEN-FAST in inpatient and outpatient populations with low-risk penicillin allergies